Outcomes of a Pregnancy with Asthma - A Case Report
Article Sidebar
Main Article Content
Abstract
Asthma is a chronic lung disease. The prevalence of asthma in pregnancy is 1-4%. Asthma can have a negative impact on maternal and fetal health. But it depends if treated adequately or not, during pregnancy. A high risk exists that asthma be complicated before and during delivery, but after delivery, it improves very soon. If asthma worsens during pregnancy, the increase in symptoms usually happens during week 24 to week 36 of pregnancy. If asthma was treated effectively during pregnancy, it can have little or no risk for complications. But, if asthma was severe or poorly controlled during pregnancy, can occur more complications, including: nausea and vomiting, vaginal bleeding, premature birth, pre-eclampsia, intrauterine growth restriction (IUGR), low birth weight, fetus with congenital malformations, complicated labor and neonatal hypoglycemia, tachypnea etc. There are many etiologic factors, that could cause asthma, including; allergens, dust mites, animal dander, etc. Then irritants as cigarette smoke, air pollution, and chemicals. Also, sinusitis, rhinitis, some medications as non-steroidal anti-inflammatory drugs (ibuprofen and naproxen), aspirin, beta blockers and others factors, including emotional stress and cold air. In our case, because of asthma the poorly controlled during pregnancy have happened complications as, preterm birth, PPROM, intrauterine growth restriction (IUGR), low birth weight and the need for neonatal intensive care.
Downloads
Article Details
Copyright (c) 2017 Gashi AM.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Sly RM, O'Donnell R (1997) Stabilization of asthma mortality. Ann Allergy Asthma Immunol 78: 347-354. Link: https://goo.gl/ENLqgP
Tan KS, Thomson NC (2000) Asthma in pregnancy. The American journal of medicine 109: 727-733. Link: https://goo.gl/3W3Nx0
Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS (2001) Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol 184: 90-96. Link: https://goo.gl/OGR94P
Enriquez R, Griffin MR, Carroll KN, Wu P, Cooper WO, et al. (2007) Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes. J Allergy Clin Immunol 120: 625-630. Link:
Källén B, Rydhstroem H, Aberg A (2000) Asthma during pregnancy–a population based study. Eur J Epidemiol 16: 167-171. Link: https://goo.gl/8ULC6B
Källén B, Danielsson BR (2014) Fetal safety of erythromycin. An update of Swedish data. Eur J Clin Pharmacol 70: 355-360. Link: https://goo.gl/eaXkRP
Tamási L, Somoskövi A, Müller V, Bártfai Z, Acs N, et al. (2006) A population-based case-control study on the effect of bronchial asthma during pregnancy for congenital abnormalities of the offspring. J Asthma 43: 81-86. Link: https://goo.gl/gC2jyc
Dombrowski MP, Schatz M (2008) ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 90, February 2008: asthma in pregnancy. Obstet Gynecol 111: 457-464. Link: https://goo.gl/k8o3Mh